Story Stocks: Dr Pepper Snapple [DPS] goes 'healthy' with Bai Brands pickup; Deal expected to be 2017 EPS dilutive

Dr Pepper Snapple (DPS 86.89, +1.64) trades about +1.9% higher after a +2.1% session yesterday follo

By |2016-11-22T13:04:00+00:00November 22nd, 2016|Briefing|Comments Off on Story Stocks: Dr Pepper Snapple [DPS] goes 'healthy' with Bai Brands pickup; Deal expected to be 2017 EPS dilutive

About the Author:

WaveGenius contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as "expects", "will," "anticipates," "estimates," "believes," or statements indicating certain actions "may," "could," or "might" occur. All statements and expressions of opinion made are the opinion of Ted Aguhob and WaveGenius and are not meant to be a solicitation or recommendation to buy, sell or hold securities. WaveGenius makes no representations, warranties or guarantees as to the accuracy or completeness of the statements made regarding the companies or stock purchases mentioned on this web site. WaveGenius does not warrant that the information on this web site and all connected and affiliated sites and services will be uninterrupted or error-free, or that any mistakes regarding that information will be corrected. WaveGenius is not a registered investment advisor or broker dealer. While it is Ted Aguhob's goal to locate and research equity investments in companies that have the potential for appreciation, investments in equity securities are risky and use of the information provided through WaveGenius is at the investor's sole risk. Investors should not rely on the information provided by WaveGenius. Rather, investors should use the information as the starting point for doing additional independent research on the companies mentioned in order to allow the investor to form his or her own opinion regarding investing in the companies mentioned. WaveGenius does not warrant or make any representations regarding the use of or the results of the use of the materials on this web site, live advice web site in terms of their correctness, accuracy, reliability, profit or otherwise. Past performance is not an indication of future performance. WaveGenius makes no representation that any account will, or is likely to, achieve profits or losses similar to those shown. Day trading or momentum trading has both potential risks and rewards. Trading stocks based on the information provided by WaveGenius may not be suitable for all users of the information provided on any of his web sites or services. You, the investor, not WaveGenius assume the entire risk of any trading that you choose to undertake. WaveGenius does not guarantee the accuracy or veracity of any statements made in the any of his services, and is not responsible for actions taken based on information provided or statements made. WaveGenius wants to emphasize this statement. products (collectively, the “Information”) are provided for informational and educational and entertainment purposes only and should not be construed as investment or financial advice.